Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CMX-2043 by Ischemix for Traumatic Brain Injury: Likelihood of Approval
CMX-2043 is under clinical development by Ischemix and currently in Phase I for Traumatic Brain Injury. According to GlobalData, Phase...
Data Insights
CMX-2043 by Ischemix for Traumatic Brain Injury: Likelihood of Approval
CMX-2043 is under clinical development by Ischemix and currently in Phase I for Traumatic Brain Injury. According to GlobalData, Phase...